title: [Humoral immune response--cervical cancer patients: lymphocytotoxic antibodies (author's transl)].
abstract: Sera of 120 cervical cancer patients as well as that of 116 healthy control persons were screened for lymphocytotoxic antibodies using microlymphocytotoxic tests variated in temperature and incubation time. In 76 of 120 cancer-sera (63.3%) lymphocytotoxic antibodies could be detected in comparison with 26 sera of 116 controls (22.4%); p less than 0.0005. With the differentiation into the stages of the disease the highest percentage of lymphocytotoxic antibodies was found in patients with stage 0 of cervical cancer. The presence of lymphocytotoxic antibodies in sera of cervical cancer patients suggest the possibility that this disease is an allotransplant as well as expression of an autoimmune process.
mesh_terms: D000961:Antilymphocyte Serum / Q000032:analysis*; D001327:Autoimmune Diseases / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D008722:Methods; D009367:Neoplasm Staging; D011247:Pregnancy; D013696:Temperature; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000276:immunology*
chemical_list: D000961:Antilymphocyte Serum
vernacular_title: Humorale Immunreaktionen bei Patientinnen mit einem Zervixkarzinom: Lymphozytotoxische Antikörper.